Increased levels of CGRP in peripheral blood in women with chronic migraine: A reliable biological marker

por Cernuda-Morollon, E, Larrosa, D, Moris, G, Ramon, C, Pascual, J
Publicado 2013

EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

por Cernuda-Morollón, E, Martínez-Camblor, P, Serrano-Pertierra, E, Larrosa, D, Ramón, C, Pascual, J
Publicado 2014

EHMTI-0104. VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine

por Cernuda-Morollón, E, Martínez-Camblor, P, Serrano-Pertierra, E, Ramón, C, Larrosa, D, Pascual, J
Publicado 2014

CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA

por Moreno-Mayordomo, R., Ruiz, M., Pascual, J., Gallego de la Sacristana, M., Vidriales, I., Sobrado, M., Cernuda-Morollon, E., Gago-Veiga, A. B., Garcia-Azorin, D., Telleria, J. J., Guerrero, A. L.
Publicado 2019